Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-16-017816
Filing Date
2016-04-08
Accepted
2016-04-08 17:00:21
Documents
1
Period of Report
2015-12-09

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 3081
  Complete submission text file 0000899243-16-017816.txt   4344
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

EIN.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RELYPSA, INC. 700 SAGINAW DR. REDWOOD CITY CA 94063
Business Address
Butler John P. (Reporting) CIK: 0001591467 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-30929 | Film No.: 161563281